Pharmacovigilance Posts | JPCC Associates

top of page

Contact@JPCCAssociates.com

JPCC ASSOCIATES

PV Consulting by PV Professionals

Search

EU Regulation 520/2012

EU Regulation 520/2012

EU Regulation 520/2012

Jennifer True

Feb 111 min read

Final Guidance on Investigator Responsibilities

Final Guidance on Investigator Responsibilities

Final Guidance on Investigator Responsibilities

Jennifer True

Jan 81 min read

Final Guidance on Sponsor Responsibilities

Final Guidance on Sponsor Responsibilities

Final Guidance on Sponsor Responsibilities

Jennifer True

Jan 82 min read

Why become a Medical Safety/PV Consultant?

Why become a Medical Safety/PV Consultant?

Why become a Medical Safety/PV Consultant?

JPCC Associates

Apr 18, 20252 min read

Should Causality Assessment Be Simple?

Should Causality Assessment Be Simple?

Should Causality Assessment Be Simple?

Jennifer True

Apr 9, 20252 min read

A Continuing Paradigm Shift

A Continuing Paradigm Shift

A Continuing Paradigm Shift

JPCC Associates

Mar 18, 20251 min read

Spontaneous reporting is great!

Spontaneous reporting is great!

Spontaneous reporting is great!

JPCC Associates

Nov 4, 20242 min read

Safety Surveillance Plans

Safety Surveillance Plans

Safety Surveillance Plans

Jennifer True

Apr 7, 20241 min read

National Adverse Event Awareness Day

National Adverse Event Awareness Day

National Adverse Event Awareness Day

JPCC Associates

Mar 20, 20241 min read

Interesting Nugget in EU CTR Q&A

Interesting Nugget in EU CTR Q&A

Interesting Nugget in EU CTR Q&A

Jennifer True

Apr 15, 20231 min read

Top 10 Signs of PV Organizational Dysfunction

Top 10 Signs of PV Organizational Dysfunction

Top 10 Signs of PV Organizational Dysfunction

JPCC Associates

Apr 28, 20223 min read

FDA Guidance of June 2021 Strengthens Guidance on Safety SurveillanceJPCC Associates

FDA Guidance of June 2021 Strengthens Guidance on Safety SurveillanceJPCC Associates

FDA Guidance of June 2021 Strengthens Guidance on Safety SurveillanceJPCC Associates

JPCC Associates

Jan 26, 20223 min read

Update on FDA Sentinel Initiative

Update on FDA Sentinel Initiative

Update on FDA Sentinel Initiative

Claudia White

Feb 14, 20193 min read

Looking for Key Performance Indicators (KPIs) in Pharmacovigilance – Part 2

Looking for Key Performance Indicators (KPIs) in Pharmacovigilance – Part 2

Looking for Key Performance Indicators (KPIs) in Pharmacovigilance – Part 2

Laura Larrú

Jan 9, 20193 min read

Looking for Key Performance Indicators (KPIs) in Pharmacovigilance

Looking for Key Performance Indicators (KPIs) in Pharmacovigilance

Looking for Key Performance Indicators (KPIs) in Pharmacovigilance

Laura Larrú

Nov 27, 20183 min read

PV GAP ANALYSIS TO TRANSFORMATION – PART 2

PV GAP ANALYSIS TO TRANSFORMATION – PART 2

PV GAP ANALYSIS TO TRANSFORMATION – PART 2

Janet Uetz

Nov 10, 20182 min read

PV GAP ANALYSIS TO TRANSFORMATION – PART 1

PV GAP ANALYSIS TO TRANSFORMATION – PART 1

PV GAP ANALYSIS TO TRANSFORMATION – PART 1

Janet Uetz

Oct 15, 20182 min read

Can We Apply Leadership Skills to Writing Pharmacovigilance SOPs?

Can We Apply Leadership Skills to Writing Pharmacovigilance SOPs?

Can We Apply Leadership Skills to Writing Pharmacovigilance SOPs?

Jean-Pierre (JP) Clement

Aug 18, 20173 min read

The Importance of the Safety Management Plan for Clinical Trials

The Importance of the Safety Management Plan for Clinical Trials

The Importance of the Safety Management Plan for Clinical Trials

Jean-Pierre (JP) Clement

Jun 30, 20173 min read

The Liabilities of Pharmacovigilance Activities

The Liabilities of Pharmacovigilance Activities

The Liabilities of Pharmacovigilance Activities

Jean-Pierre (JP) Clement

Jun 21, 20173 min read

bottom of page